$CI

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$CIr/wallstreetbetsDiscussionbullish

u/Sufficient-Flan1565 · 5d ago1 prior · awaiting results

Cigna (CI) looks cheap

Cigna trades at ~9.2x forward P/E with $279/share valuation, supported by strong Q2 revenue growth (+7% YoY), $9.6B operating cash flow, and $6.5B buyback authorization. A conservative DCF model suggests intrinsic value around $390/share, implying substantial margin of safety despite regulatory headwinds priced into the low multiple.

original post →

$CIr/ValueInvestingStock Analysisbullish

u/Sufficient-Flan1565 · 6d ago1 prior · awaiting results

Cigna (CI) looks surprisingly cheap

Cigna trades at a 9.2x forward P/E on 2026 EPS guidance of $30.45, appearing deeply discounted relative to conservative DCF valuation around $390/share. While PBM regulation poses genuine risk, the company's strong cash generation, 7% revenue growth, and aggressive buybacks suggest significant upside if regulatory concerns ease.

original post →

End of results.